Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 21 2013
Print RSS Feed

Breaking News

Related Searches: Financial Reports •
Financial Report: Pfizer 4Q

February 3, 2010
Pfizer completed its acquisition of Wyeth in the quarter. U.S. revenues were $7.4 billion in the quarter (+42%).  Read More »
Financial Report: Roche

February 3, 2010
The company achieved record sales for the year.  Read More »
Auxilium Gains Approval for Xiaflex

February 3, 2010
Auxilium Pharmaceuticals has received marketing approval from the FDA for Xiaflex (collagenase clostridium histolyticum), a first in class, orphan-designated, biologic for the treatment of adult Dupuytren's contracture patients with a palpable cord.  Read More »
CTI

February 3, 2010
Robert Patton has been appointed vice president of business development at Clinical Trial and Consulting Services (CTI).   Read More »
Catalent

February 2, 2010
Kurt Nielsen, Ph.D., has been appointed chief technology officer and senior vice president of innovation and growth at Catalent Pharma Solutions, Inc.   Read More »
Dalton Pharma Successfully Completes Inspection

February 2, 2010
Dalton Pharma Services has successfully completed its Health Canada audit and has received a 'compliant' rating for its GMP manufacturing facility.  Read More »
Abbott, Pierre Fabre Enter Cancer R&D Pact

February 2, 2010
Abbott has entered an exclusive worldwide licensing agreement with Pierre Fabre SA to develop and commercialize h224G11, a preclinical monoclonal antibody targeting the cMet receptor for the potential treatment of cancer.  Read More »
Corning, Sartorius Stedim Enter Cell Culture Product Pact

February 2, 2010
Corning, Inc. and Sartorius Stedim Biotech have entered a marketing and branding collaboration to offer a full range of cell culture products through a combined product catalogue.  Read More »
Catalent Adds Potent Drug Capabilities at German Site

February 1, 2010
Catalent Pharma Solutions has expanded its capabilities to include a new potent products area at its Schorndorf site in Germany.  Read More »
Tykerb Combo Gains Accelerated Approval

February 1, 2010
GlaxoSmithKline received accelerated approval from the FDA for a new combination regimen using Tykerb (lapatinib) as a first-line, oral treatment for women with metastatic breast cancer.  Read More »
Cephalon to Acquire Mepha AG

February 1, 2010
Cephalon, Inc. has signed an agreement to acquire Mepha AG and its subsidiaries for $590 million.  Read More »
Regis Passes Inspections to Manufacture Ampyra

January 29, 2010
Regis Technologies, Inc. received an Establishment Inspection Report (EIR) from the FDA stating that the company has passed pre-approval inspection (PAI) for the manufacture of 4-Aminopyridine, the active ingredient in Ampyra.  Read More »
Quintiles, Movetis In Commercialization Pact

January 29, 2010
Quintiles has entered into a strategic alliance with Movetis NV for the commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany.  Read More »
Cephalon, Inc.

January 29, 2010
Cephalon, Inc. has promoted three executives, Kevin Buchi, Wilco Groenhuysen and Alain Aragues.  Read More »
Quintiles

January 29, 2010
Bill Truhe has been appointed pharmacovigilance solutions leader for Quintiles, responsible for building a drug safety consulting service practice.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: